Table 1.
Oocyte cryopreservation cycle outcomes
| Patient characteristics and cycle details | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
|---|---|---|---|---|---|
| Age at presentation (years) | 14 | 18 | 18 | 16 | 16 |
| AMH (ng/mL) | 6.5 | 5.9 | 5.9 | 3.6 | 4.3 |
| Starting gonadotropin dose (IU) | 150 rFSH 75 hMG |
150 rFSH | 150 rFSH | 150 rFSH | 100 rFSH 75 hMG |
| Total gonadotropin dose (IU) | 2675 | 1150 | 2050 | 3300 | 1725 |
| Duration of stimulation (days) | 9 | 9 | 10 | 11 | 9 |
| Estradiol level on day of trigger (pg/mL) | 1446 | 3246 | 1016 | 2215 | 2475 |
| Modality of ultrasound monitoring | Abdominal | Vaginal | Vaginal | Vaginal | Vaginal |
| Total number of oocytes retrieved | 11 | 19 | 13 | 20 | 28 |
| Number of mature oocytes cryopreserved | 8 | 14 | 13 | 11 | 25 |
AMH antimullerian hormone, rFSH recombinant follicle stimulating hormone, hMG human menopausal gonadotropin